Astera Labs Inc. (ALAB) concluded trading on Thursday at a closing price of $54.75, with 3.79 million shares of worth about $207.76 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -31.49% during that period and on September 26, 2024 the price saw a gain of about 5.09%. Currently the company’s common shares owned by public are about 155.47M shares, out of which, 110.08M shares are available for trading.
Stock saw a price change of 16.17% in past 5 days and over the past one month there was a price change of 22.46%. Over the period of past 52 weeks, stock dropped to lowest price of $36.22 but also hit the highest price of $95.21 during that period. The average intraday trading volume for Astera Labs Inc. shares is 2.71 million. The stock is currently trading 23.22% above its 20-day simple moving average (SMA20), while that difference is up 23.99% for SMA50 and it goes to -7.23% lower than SMA200.
Astera Labs Inc. (NASDAQ: ALAB) currently have 155.47M outstanding shares and institutions hold larger chunk of about 32.09% of that.
The stock has a current market capitalization of $8.58B. It has posted earnings per share of -$0.57 in the same period. It has Quick Ratio of 13.46 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALAB, volatility over the week remained 4.74% while standing at 6.84% over the month.
Stock’s fiscal year EPS is expected to rise by 609.02% while it is estimated to increase by 46.90% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on September 04, 2024 offering an Overweight rating for the stock and assigned a target price of $55 to it. Coverage by Evercore ISI stated Astera Labs Inc. (ALAB) stock as an Outperform in their note to investors on April 16, 2024, suggesting a price target of $100 for the stock. On April 15, 2024, Stifel Initiated their recommendations, while on April 15, 2024, ROTH MKM Initiated their ratings for the stock with a price target of $85. Stock get a Buy rating from Needham on April 15, 2024.
